Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation

Cell Metab. 2014 Sep 2;20(3):417-32. doi: 10.1016/j.cmet.2014.06.009. Epub 2014 Jul 17.

Abstract

The activity of chaperone-mediated autophagy (CMA), a catabolic pathway for selective degradation of cytosolic proteins in lysosomes, decreases with age, but the consequences of this functional decline in vivo remain unknown. In this work, we have generated a conditional knockout mouse to selectively block CMA in liver. We have found that blockage of CMA causes hepatic glycogen depletion and hepatosteatosis. The liver phenotype is accompanied by reduced peripheral adiposity, increased energy expenditure, and altered glucose homeostasis. Comparative lysosomal proteomics revealed that key enzymes in carbohydrate and lipid metabolism are normally degraded by CMA and that impairment of their regulated degradation contributes to the metabolic abnormalities observed in CMA-defective animals. These findings highlight the involvement of CMA in regulating hepatic metabolism and suggest that the age-related decline in CMA may have a negative impact on the energetic balance in old organisms.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autophagy*
  • Carbohydrate Metabolism
  • Fatty Liver / genetics*
  • Fatty Liver / metabolism
  • Fatty Liver / pathology*
  • Female
  • Homeostasis
  • Lipid Metabolism
  • Liver / metabolism*
  • Liver / pathology*
  • Lysosomal-Associated Membrane Protein 2 / genetics*
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Male
  • Mice
  • Mice, Knockout

Substances

  • Lysosomal-Associated Membrane Protein 2

Associated data

  • GEO/GSE49553